Skip to main content
Clinical Trials/KCT0006452
KCT0006452
Recruiting
未知

Shared Decision Making for choosing renAl Replacement Therapy in chronic kidney disease patients

Seoul National University Bundang Hospital0 sites1,194 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the genitourinary system
Sponsor
Seoul National University Bundang Hospital
Enrollment
1194
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Chronic kidney disease grade 5 (defined as estimated glomerular filtration rate \< 15 ml/dL/1\.73m2 at least 2 times at intervals of 2 weeks or longer)
  • Age between 19 and 80 years
  • The nephrologists anticipate treating the patient with kidney replacement therapy within 12 months
  • Written informed consent

Exclusion Criteria

  • Contraindication to perform peritoneal dialysis due to abdominal surgery
  • Life expectancy is less than 6 months due to underlying diseases
  • Patients who have enrolled in other clinical trials within 3 months or plan to participate in other clinical trials during this clinical trial period
  • Patients judged by the investigator to be inappropriate for participation in this clinical trial.

Outcomes

Primary Outcomes

Not specified

Similar Trials